|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/506 | |
| A61P 7/00 | |||
| A61P 37/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 1879585 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06751956.1 |
| Date of filing the European patent application | 2006-05-01 | |
| (97) | Date of publication of the European application | 2008-01-23 |
| (45) | Date of publication and mention of the grant of the patent | 2013-04-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/016541 |
| Date | 2006-05-01 |
| (87) | Number | WO 2006/119154 |
| Date | 2006-11-09 |
| (30) | Number | Date | Country code |
| 676740 P | 2005-05-02 | US |
| (72) |
ALLAND, Leila, US
FABBRO, Doriano, CH
MESTAN, Jürgen, DE
MANLEY, Paul, W., CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Novartis Pharma GmbH, Brunner Strasse 59, 1230 Wien, AT |
| (54) | USE OF PYRIMIDYLAMIMOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF SYSTEMIC MASTOCYTOSIS |
| USE OF PYRIMIDYLAMIMOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF SYSTEMIC MASTOCYTOSIS |